Two obscure but large factors in this stock that should be discussed but aren't being reported: (1) TEVA is under criminal prosecution (by U.S. states attorneys general) for mob-like collusion with their lowball competitors, with plenty of red-handed evidence. Witness the doxycycline scandal over recent years. (2) TEVA appears to be quietly converting the generics business to merely reselling Indian product. The Indians in turn seem to be in the transhipping racket, secretly relabeling Chinese drugs (witness the recent valsartan recall surprise revelations) into Indian bottles. Meanwhile the FDA has no jurisdiction and little knowledge of foreign sources and transhipping, just spotty, unenforceable testing and inspection, and embargo as the only weak recourse. This sets up an industry-wide risk of ruin. Americans, who don't trust India or China for stuff to eat, are somehow trapped into swallowing Chinese pills?! If you take an Rx generic drug, ask your pharmacist to show you the wholesale bottle's label next time you fill it. Chances are your retail Rx label cites a U.S. manufacturer name, but the wholesale package will state an Indian source. Chances are your pharmacist is unaware of this, or will at least act unaware, and assure you don't worry the FDA has you covered. The FDA regulates no manufacturing outside the U.S. At most they spot inspect without enforcement. Interdiction is not enforcement, it just shuts down consumers. Meanwhile U.S. manufacturing is shut down. We're trapped. The FDA does jurisdict U.S. consumers. A decade ago they interdicted us from filling generic Rx's through India over the Internet, saying the 3rd world products were unsafe filth. Somehow the same Asian products fill U.S. pharmacy shelves now. That's how WalMart can give a long list of them away, they're that cheap and unregulated. $TEVA, Teva Pharmaceutical Industries Limited / H1